{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11567542", "DateCompleted": {"Year": "2001", "Month": "12", "Day": "05"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1521-6942", "JournalIssue": {"Volume": "15", "Issue": "4", "PubDate": {"Year": "2001", "Month": "Oct"}}, "Title": "Best practice & research. Clinical rheumatology", "ISOAbbreviation": "Best Pract Res Clin Rheumatol"}, "ArticleTitle": "Nutripharmaceuticals for osteoarthritis.", "Pagination": {"StartPage": "595", "EndPage": "607", "MedlinePgn": "595-607"}, "Abstract": {"AbstractText": ["What is the level of evidence for current symptomatic agents (SYSADOA) in patients with osteoarthritis? Existing publications which met the inclusion criteria were rated by calculating the effect size of the compounds and applying a quality assessment score of the study methodology. This produced a median effect size for the primary outcome measure, pain, of 1.37 (range 0.37-1.50) for chondroitin-sulphate and 0.57 (range 0.26-1.02) for glucosamine-sulphate in patients with knee osteoarthritis. These effect sizes were strongly diminished when only recent high-quality studies were considered (effect size of pain for chondroitin-sulphate 0.37 and for glucosamine-sulphate 0.26). Effect sizes for functional improvement and overall WOMAC index (pain, stiffness and function) were in the same range for both compounds. So far, and in contrast to recent claims, there is no reliable scientific evidence that these two substances have structure-modifying actions with respect to prohibiting, healing or restoring cartilage lesions. There is only scarce or no scientific evidence for the effects of nutrients in patients with knee, hip or hand osteoarthritis. Several large company-sponsored and independent trials with several of these nutripharmaceuticals are ongoing in Europe and the USA."], "CopyrightInformation": "Copyright 2001 Harcourt Publishers Ltd."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Rheumatology and Bone Disease, Klinik Im Park, Bellariastr.38, CH 8038, Switzerland."}], "Identifier": [], "LastName": "H\u00e4uselmann", "ForeName": "H J", "Initials": "HJ"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Best Pract Res Clin Rheumatol", "NlmUniqueID": "101121149", "ISSNLinking": "1521-6942"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Nonprescription Drugs"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Trace Elements"}, {"RegistryNumber": "0", "NameOfSubstance": "Vitamins"}, {"RegistryNumber": "9007-28-7", "NameOfSubstance": "Chondroitin Sulfates"}, {"RegistryNumber": "N08U5BOQ1K", "NameOfSubstance": "Glucosamine"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Chondroitin Sulfates"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Glucosamine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Meta-Analysis as Topic"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Nonprescription Drugs"}, {"QualifierName": ["rehabilitation"], "DescriptorName": "Osteoarthritis, Hip"}, {"QualifierName": ["rehabilitation"], "DescriptorName": "Osteoarthritis, Knee"}, {"QualifierName": [], "DescriptorName": "Persea"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Glycine max"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Trace Elements"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Vitamins"}], "NumberOfReferences": "45"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "9", "Day": "25", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "1", "Day": "5", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "9", "Day": "25", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11567542", "10.1053/berh.2001.0176", "S1521694201901767"]}}], "PubmedBookArticle": []}